癌症研究
生物
癌变
肝细胞癌
转录因子
细胞周期
细胞生长
染色质免疫沉淀
医学
癌症
遗传学
基因
基因表达
发起人
作者
Liu R,Jincheng Li,Shi-De Li,Jian‐Di Li,Rong‐Quan He,Gang Chen,Zhen-Bo Feng,Jialiang Wei
出处
期刊:PubMed
[National Institutes of Health]
日期:2025-07-27
卷期号:17 (7): 106151-106151
标识
DOI:10.4254/wjh.v17.i7.106151
摘要
This study identified RAC3 as a key HCC oncogenic driver; its overexpression links to poor prognosis/resistance. Targeting the RAC3/E2F1 axis offers a new therapy, which highlights RAC3 as a biomarker/target.
科研通智能强力驱动
Strongly Powered by AbleSci AI